Each year, the German Liver Foundation honors a groundbreaking publication with the "German Liver Foundation Award". This year, the award went to a fundamental scientific study that examines the potential effects of intermittent fasting on metabolically induced steatohepatitis and the resulting liver cancer.

Numerous researchers applied or were nominated for the 2025 award for an outstanding publication in the field of hepatology. Submissions were reviewed by an independent panel consisting of Prof. Dr. Christian Lange (Munich), Prof. Dr. Felix Stickel (Bern, Switzerland), and Prof. Dr. Andrea Tannapfel (Bochum).

After evaluation and discussion of the submitted works, the committee unanimously decided to award a publication where besides Dr. Gallage numerous other M3 Researchers worked on:

Publication:
Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, Nogayhan Seymen, Pierluigi Ramadori, Vera Joerke, Laimdota Zizmare, David Aicher, Indresh K. Gopalsamy, Winnie Fong, Jan Kosla, Enrico Focaccia, Xin Li, Suhail Yousuf, Tjeerd Sijmonsma, Mohammad Rahbari, Katharina S. Kommoss, Adrian Billeter, Sandra Prokosch, Ulrike Rothermel, Florian Mueller, Jenny Hetzer, Danijela Heide, Benjamin Schinkel, Tim Machauer, Bernd Pichler, Nisar P. Malek, Thomas Longerich, Susanne Roth, Adam J. Rose, Johannes Schwenck, Christoph Trautwein, Mohammad M. Karimi, and Mathias Heikenwälder:
"A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1",
Cell Metabolism 36, 1371–1393, June 4, 2024